Interestingly, from the data in cBioPortal, mutations in CARD11 and PIM1 tended to co-occur in 29/1295 DLBCL patients with high significance (Fisher’s exact test, p-value: 0.03). Here, PIM1 is linked to diffuse large B-cell lymphoma.